Health department confirms 5mg Enalapril safety following 10mg recall

AI-summarized · Neutrality-checked

The Department of Health in Lesotho issued a statement confirming that the 5mg version of Enalapril remained safe for use, following a recall of the 10mg version manufactured by Arya Pharma. Spokesperson Foster Mohale clarified that the recall, initiated by the South African Health Products Regulatory Authority (SAHPRA), did not extend to the 5mg tablets currently supplied to public health facilities. The 10mg tablets had been approved as a temporary substitute during production delays by the usual supplier, Austell Pharmaceuticals. Health officials urged patients not to stop their prescribed treatment to avoid unnecessary disruption to their care.

Consequences

Public health facilities are expected to continue distributing the 5mg Enalapril tablets as they meet all required quality and registration standards. Authorities have instructed provincial health facilities to inform staff of the situation to prevent further public concern regarding the safety of their medication.

Sources

Know where. Know why.